vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Newton Golf Company, Inc. (NWTG). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.3M, roughly 1.7× Newton Golf Company, Inc.). On growth, Newton Golf Company, Inc. posted the faster year-over-year revenue change (112.4% vs -10.2%). Over the past eight quarters, Newton Golf Company, Inc.'s revenue compounded faster (155.0% CAGR vs 50.3%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Bridgestone Golf, Inc. is a sports equipment company based in Covington, Georgia, United States. The company is a subsidiary of Bridgestone. It designs and manufactures a full range of golf equipment including balls, clubs, and accessories utilizing both the Bridgestone and Precept brand names.

IRD vs NWTG — Head-to-Head

Bigger by revenue
IRD
IRD
1.7× larger
IRD
$3.9M
$2.3M
NWTG
Growing faster (revenue YoY)
NWTG
NWTG
+122.6% gap
NWTG
112.4%
-10.2%
IRD
Faster 2-yr revenue CAGR
NWTG
NWTG
Annualised
NWTG
155.0%
50.3%
IRD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRD
IRD
NWTG
NWTG
Revenue
$3.9M
$2.3M
Net Profit
$-2.4M
Gross Margin
25.0%
Operating Margin
-112.8%
Net Margin
-105.3%
Revenue YoY
-10.2%
112.4%
Net Profit YoY
53.0%
71.3%
EPS (diluted)
$-0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
NWTG
NWTG
Q4 25
$3.9M
$2.3M
Q3 25
$3.1M
$2.6M
Q2 25
$2.9M
$2.1M
Q1 25
$4.4M
$1.2M
Q4 24
$4.3M
$1.1M
Q3 24
$3.9M
$1.2M
Q2 24
$1.1M
$813.0K
Q1 24
$1.7M
$350.0K
Net Profit
IRD
IRD
NWTG
NWTG
Q4 25
$-2.4M
Q3 25
$-17.5M
$-1.6M
Q2 25
$-7.4M
$-1.5M
Q1 25
$-8.2M
$-525.0K
Q4 24
$-8.3M
Q3 24
$-7.5M
$-1.1M
Q2 24
$-7.8M
$-1.2M
Q1 24
$-7.1M
$-1.2M
Gross Margin
IRD
IRD
NWTG
NWTG
Q4 25
25.0%
Q3 25
67.2%
Q2 25
67.6%
Q1 25
70.4%
Q4 24
72.3%
Q3 24
66.5%
Q2 24
60.1%
Q1 24
58.9%
Operating Margin
IRD
IRD
NWTG
NWTG
Q4 25
-112.8%
Q3 25
-269.9%
-58.2%
Q2 25
-309.0%
-72.9%
Q1 25
-227.2%
-162.9%
Q4 24
-133.6%
Q3 24
-207.1%
-90.0%
Q2 24
-748.9%
-147.8%
Q1 24
-450.5%
-358.6%
Net Margin
IRD
IRD
NWTG
NWTG
Q4 25
-105.3%
Q3 25
-566.9%
-61.2%
Q2 25
-257.5%
-73.5%
Q1 25
-187.5%
-43.4%
Q4 24
-779.1%
Q3 24
-194.6%
-87.5%
Q2 24
-698.3%
-142.1%
Q1 24
-415.3%
-340.9%
EPS (diluted)
IRD
IRD
NWTG
NWTG
Q4 25
$-0.40
Q3 25
$-0.25
$-0.34
Q2 25
$-0.12
$-0.34
Q1 25
$-0.24
$-0.55
Q4 24
$-131.23
Q3 24
$-0.29
$-21.79
Q2 24
$-0.30
$-0.79
Q1 24
$-0.29
$-24.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
NWTG
NWTG
Cash + ST InvestmentsLiquidity on hand
$45.1M
$1.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.3M
$926.0K
Total Assets
$50.2M
$3.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
NWTG
NWTG
Q4 25
$45.1M
$1.3M
Q3 25
$30.8M
$2.5M
Q2 25
$32.4M
$4.0M
Q1 25
$41.8M
$5.9M
Q4 24
$30.3M
$7.7M
Q3 24
$36.6M
$1.3M
Q2 24
$41.4M
$2.8M
Q1 24
$47.2M
$4.1M
Stockholders' Equity
IRD
IRD
NWTG
NWTG
Q4 25
$15.3M
$926.0K
Q3 25
$6.0M
$3.1M
Q2 25
$17.5M
$4.4M
Q1 25
$5.1M
$6.2M
Q4 24
$6.7M
$-5.2M
Q3 24
$34.3M
$2.6M
Q2 24
$40.6M
$3.6M
Q1 24
$46.1M
$4.7M
Total Assets
IRD
IRD
NWTG
NWTG
Q4 25
$50.2M
$3.3M
Q3 25
$36.1M
$5.3M
Q2 25
$38.7M
$6.5M
Q1 25
$48.2M
$8.2M
Q4 24
$36.9M
$9.8M
Q3 24
$40.4M
$3.4M
Q2 24
$44.8M
$4.2M
Q1 24
$51.8M
$5.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
NWTG
NWTG
Operating Cash FlowLast quarter
$-35.3M
$-1.1M
Free Cash FlowOCF − Capex
$-1.1M
FCF MarginFCF / Revenue
-50.5%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
NWTG
NWTG
Q4 25
$-35.3M
$-1.1M
Q3 25
$-6.2M
$-1.3M
Q2 25
$-10.3M
$-1.2M
Q1 25
$-9.0M
$-1.6M
Q4 24
$-25.6M
$-1.5M
Q3 24
$-5.1M
$-1.1M
Q2 24
$-7.3M
$-1.2M
Q1 24
$-5.7M
$-1.2M
Free Cash Flow
IRD
IRD
NWTG
NWTG
Q4 25
$-1.1M
Q3 25
$-1.4M
Q2 25
$-1.4M
Q1 25
$-1.7M
Q4 24
$-1.5M
Q3 24
$-1.4M
Q2 24
$-1.3M
Q1 24
$-1.2M
FCF Margin
IRD
IRD
NWTG
NWTG
Q4 25
-50.5%
Q3 25
-54.9%
Q2 25
-66.4%
Q1 25
-140.1%
Q4 24
-143.5%
Q3 24
-112.7%
Q2 24
-159.3%
Q1 24
-352.6%
Capex Intensity
IRD
IRD
NWTG
NWTG
Q4 25
3.7%
Q3 25
3.6%
Q2 25
7.7%
Q1 25
10.8%
Q4 24
3.6%
Q3 24
22.7%
Q2 24
12.9%
Q1 24
23.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRD
IRD

Segment breakdown not available.

NWTG
NWTG

Online Sales$2.1M93%
Other$151.0K7%

Related Comparisons